Clementia Pharmaceuticals (CMTA) Return on Equity ROE from the fourth quarter 2018 to fourth quarter 2017 and annually, average high and low, overall ranking from Dec 31 2018 to Dec 31 2017 - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Clementia Pharmaceuticals Inc.  (CMTA)

Clementia Pharmaceuticals's ROE per quarter

Return on Equity, Quarterly Results, Trends, Rankings, Statistics


What is ROE for Clementia Pharmaceuticals in the fourth quarter 2018?
Clementia Pharmaceuticals Inc. recorded a cumulative net loss of $-58 million during 12 months ending in the fourth quarter 2018, resulting in a negative return on equity (ROE) of -44.72%.

Within the Major Pharmaceutical Preparations industry 138 other companies had a higher return on equity. While return on equity, the total ranking has deteriorated compared to the third quarter 2018 from 0 to 4003.

What is ROE?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Equity (Dec 31 2018)
IV. Quarter		 (Sep 30 2018)
III. Quarter		 (Jun 30 2018)
II. Quarter		 (Mar 31 2018)
I. Quarter		 (Dec 31 2017)
IV. Quarter
Y / Y Equity Change 16.04 % -30.24 % - - -
Y / Y Net Income Change - - - - -
Net Income (TTM) in Millions -58 -51 -75 -87 -115
Return On Equity (TTM) -44.72 % -40.68 % -55.05 % -165.52 % -
CMTA's Total Ranking # 4003 # 0 # 0 # 0 # 0
Equity (TTM) in Millions 164 107 120 129 142
Seq. Equity Change 54.26 % -10.96 % -7.35 % -8.82 % -7.26 %
Seq. Net Income Change - - - - -

Back to CMTA Management Effectiveness >> CMTA's 5 Years Annual ROE >> Compare CMTA ROE to its Competitors
Return On Equity Company Ranking
Within: No.
Industry # 139
Sector # 341
Overall # 4003

Return On Equity Statistics
High Average Low
-35.35 %
-35.35 %
-35.35 %
(Dec 31 2018)  





CMTA Annual Return On Equity (Dec 31 2018)
2018		 (Dec 31 2017)
2017


Total Equity in Millions 164 142 0 0 0
Y / Y Equity Change 16.04 % - - - -
Net Income in Millions -58 -115 0 0 0
Y / Y Net Income Change - - - - -
Return On Equity -35.35 % -81.47 % - - -

Back to CMTA Management Effectiveness >> CMTA's 5 Years Annual ROE >> Compare CMTA ROE to its Competitors




More Return On Equity Ratios
Major Pharmaceutical Preparations Industry Roe Trends and Statistics
Healthcare Sector Return On Equity Statistics
CMTA's' Return on Equity at Yahoo Finance
CMTA's Roe Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and overall Market
Highest Ranking Return On Equity
Lowest Ranking Return On Equity
Subscribers only: Roe for CMTA's Competitors
Subscribers only: Roe for Clementia Pharmaceuticals's Suppliers
Subscribers only: Return On Equity for CMTA's Customers




Companies with similar Return On Equity at Dec 31 2018, within Healthcare Sector ROE

Date modified: 2026-09-05T11:07:08+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.